Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
61 studies found for:    "Kidney Neoplasms" AND (woman OR women OR female)
Show Display Options
Rank Status Study
1 Completed Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy
Conditions: Bladder Cancer;   Cervical Cancer;   Esophageal Cancer;   Gastric Cancer;   Head and Neck Cancer;   Kidney Cancer;   Leukemia;   Liver Cancer;   Lung Cancer;   Pancreatic Cancer;   Tobacco Use Disorder
Interventions: Behavioral: Smoking Prevention Usual Care;   Behavioral: Counseling Intervention
2 Recruiting Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors
Conditions: Neoplasms;   Neoplasms, Glandular and Epithelial;   Neoplasms by Histologic Type;   Bronchial Neoplasms;   Lung Neoplasms;   Respiratory Tract Neoplasms;   Thoracic Neoplasms;   Digestive System Neoplasms;   Endocrine Gland Neoplasms;   Carcinoma, Non-Small-Cell Lung;   Lung Diseases;   Breast Neoplasms;   Breast Diseases;   Renal Neoplasm;   Solid Tumors
Interventions: Drug: Entinostat;   Other: Placebo
3 Recruiting Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer
Conditions: Adult Liver Carcinoma;   Breast Carcinoma;   Colon Carcinoma;   Kidney Neoplasm;   Lung Carcinoma;   Malignant Head and Neck Neoplasm;   Malignant Neoplasm;   Melanoma;   Ovarian Neoplasm;   Soft Tissue Sarcoma
Interventions: Procedure: Hyperthermia Treatment;   Other: Laboratory Biomarker Analysis
4 Not yet recruiting MED-C Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Conditions: Neoplasms;   Lung Neoplasms;   Colon Neoplasms;   Breast Neoplasms;   Pancreatic Neoplasms;   Prostate Neoplasms;   Kidney Neoplasms;   Liver Neoplasms;   Rectal Neoplasms;   Hematologic Neoplasms;   Multiple Myeloma;   Myelodysplastic Syndromes;   Ovarian Neoplasms;   Bladder Neoplasms;   Testicular Neoplasms;   Endometrial Neoplasms;   Brain Neoplasms;   Biliary Tract Neoplasms;   Head and Neck Neoplasms;   Uterine Cervical Neoplasms;   Skin Neoplasms;   Melanoma;   Gastric Neoplasms;   Anal Neoplasms;   Sarcoma
Intervention: Other: Provider determined
5 Completed Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence
Conditions: Sarcoma;   Multiple Myeloma;   Testicular Neoplasms;   Ovarian Neoplasms;   Kidney Neoplasms
Intervention: Procedure: Positron Emission Tomography
6 Recruiting MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors
Conditions: Non-Small Cell Lung Cancer;   Nonsmall Cell Lung Cancer;   Breast Cancer;   Cancer of Breast;   Cancer of the Breast;   Gastroesophageal Cancer;   Pancreatic Cancer;   Cancer of the Pancreas;   Colorectal Cancer;   Colorectal Carcinoma;   Renal Cancer;   Kidney Cancer;   Cancer of the Kidney;   Cancer of Kidney;   Ovarian Cancer;   Ovary Cancer;   Cancer of the Ovary;   Cancer of Ovary
Intervention: Drug: MEDI4736
7 Completed
Has Results
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Conditions: Anemia;   Breast Cancer;   Cancer;   Colorectal Cancer;   Lung Cancer;   Ovarian Cancer;   Prostate Cancer;   Solid Tumors;   Bladder Cancer;   Endometrial Cancer;   Renal Cancer;   Pancreatic Cancer;   Esophageal Cancer;   Gastric Cancer
Intervention:
8 Active, not recruiting
Has Results
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma
Conditions: Ovarian Cancer;   Renal Cancer;   Non-small Cell Lung Cancer;   Small Cell Lung Cancer;   Solid Tumors;   Multiple Myeloma;   Lymphoma
Interventions: Drug: Carfilzomib;   Drug: Dexamethasone
9 Recruiting The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
Conditions: Bladder Cancer;   Colorectal Cancer;   Endometrial Cancer;   Kidney Cancer;   Skin Cancer;   Uterus Cancer
Intervention: Behavioral: Health and Diet Questionnaire
10 Completed Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2
Conditions: Breast Neoplasm;   Pancreatic Neoplasm;   Lung Neoplasm;   Ovarian Neoplasm;   Renal Neoplasm
Intervention: Drug: TAK-165
11 Completed
Has Results
Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer
Conditions: Lung Neoplasms;   Ovarian Neoplasms;   Cervix Neoplasms;   Renal Neoplasms
Interventions: Drug: docetaxel;   Drug: tariquidar;   Other: 99mTc-sestamibi imaging
12 Completed A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing
Conditions: Breast Cancer;   Ovarian Cancer;   Prostate Cancer;   Colon Cancer;   Renal Cancer
Intervention: Drug: Cyclophosphamide & ZYC300 (ZYC300 with cyclophosphamide pre-dosing)
13 Completed Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors
Conditions: Breast Cancer;   Colorectal Cancer;   Head and Neck Cancer;   Kidney Cancer;   Lung Cancer;   Ovarian Cancer;   Pancreatic Cancer;   Prostate Cancer;   Sarcoma
Interventions: Drug: bortezomib;   Drug: gemcitabine hydrochloride
14 Active, not recruiting Pillars4Life Trial
Conditions: Breast Cancer;   Lung Cancer;   Esophageal Cancer;   Colon Cancer;   Pancreatic Cancer;   Liver Cancer;   Renal Cancer;   Bladder Cancer;   Prostate Cancer;   Ovarian Cancer;   Cervical Cancer;   Uterine Cancer
Intervention: Behavioral: Pillars4Life
15 Recruiting Prospective Analysis of Robot-Assisted Surgery
Conditions: Esophageal Cancer;   Gastric Cancer;   Pancreatic Cancer;   Rectal Cancer;   Bladder Cancer;   Prostate Cancer;   Renal Cancer;   Uterus Cancer;   Head and Neck Cancer;   Lung Cancer
Interventions: Procedure: Robot-assisted surgery;   Procedure: Conventional Surgery
16 Completed Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors
Conditions: Cervical Cancer;   HEENT Cancer;   Renal Cancer;   Uterine Cancer;   CERVIX UTERI NOS;   RECTUM
Intervention: Radiation: 124I-Iodo-Azomycin Galacto-Pyranoside
17 Recruiting Survivorship Promotion In Reducing IGF-1 Trial
Conditions: Breast Cancer;   Prostate Cancer;   Lung Cancer;   Colon Cancer;   Melanoma of Skin;   Endometrial Cancer;   Liver Cancer;   Pancreatic Cancer;   Rectal Cancer;   Kidney Cancer;   Other Solid Malignant Tumors
Interventions: Drug: Metformin;   Behavioral: Coach Directed Behavioral Weight Loss;   Behavioral: Self-control weight loss
18 Completed Acceptability of Less Harmful Alternatives to Cigarettes
Conditions: Bladder Cancer;   Cervical Cancer;   Esophageal Cancer;   Gastric Cancer;   Head and Neck Cancer;   Kidney Cancer;   Leukemia;   Liver Cancer;   Lung Cancer;   Pancreatic Cancer;   Tobacco Use Disorder
Interventions: Behavioral: telephone-based intervention;   Drug: nicotine replacement therapy;   Other: informational intervention;   Other: internet-based intervention;   Other: questionnaire administration
19 Completed
Has Results
Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking
Conditions: Bladder Cancer;   Cervical Cancer;   Esophageal Cancer;   Gastric Cancer;   Head and Neck Cancer;   Kidney Cancer;   Leukemia;   Liver Cancer;   Lung Cancer;   Pancreatic Cancer;   Tobacco Use Disorder
Interventions: Drug: nicotine;   Drug: varenicline;   Other: placebo
20 Completed Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking
Conditions: Bladder Cancer;   Cervical Cancer;   Esophageal Cancer;   Gastric Cancer;   Head and Neck Cancer;   Kidney Cancer;   Leukemia;   Liver Cancer;   Lung Cancer;   Pancreatic Cancer;   Tobacco Use Disorder
Interventions: Behavioral: smoking cessation intervention;   Drug: bupropion hydrochloride;   Genetic: gene expression analysis;   Genetic: polymerase chain reaction;   Other: counseling intervention;   Other: educational intervention;   Procedure: psychosocial assessment and care

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years